Drug intelligence / Profile preview

GNPs-Dox-Lac

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Intravenous
01

Overview

**GNPs-Dox-Lac** is an experimental, enzyme-responsive and pH-responsive nanomedicine for hepatocellular carcinoma. It consists of gelatin nanoparticles carrying a lactose-conjugated doxorubicin prodrug, doxorubicin-lactose. The approximately 133 nm gelatin carrier is designed to remain stable during circulation and accumulate in tumors; tumor-associated matrix metalloproteinase-2 degrades the gelatin matrix, releasing the smaller doxorubicin-lactose prodrug to improve tumor penetration and cellular uptake. Intracellular acidic conditions then dissociate the prodrug and release free doxorubicin, which intercalates DNA and inhibits topoisomerase II, causing DNA damage and cytotoxicity. In an in vivo hepatocellular carcinoma model, the system produced a reported tumor-inhibition rate of 90.8% with comparatively low toxicity.

Other names
GNPs-DOX-Lac
02

Targets

TOP2B (DNA topoisomerase II beta)DNATOP2A (DNA topoisomerase II)

Beyond the preview

Go deeper on GNPs-Dox-Lac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GNPs-Dox-Lac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call